FIELD: pharmacy. SUBSTANCE: preparation is the combined formula consisting of a mixture of interferon and substance containing 2.2% polyunsaturated fatty acids, not less, and showing antioxidant property. The latter substance is eiconol that has 28-30% polyunsaturated fatty acids. Preparation has components at the following amounts: interferon 500000 IU, polyunsaturated fatty acids 0.045-0.08 g. Preparation can be made as rectal capsule or suppository and administrated by rectal route. Preparation can be used for treatment viral, bacterial infections and chlamydiosis and other diseases passing on immunodeficiency background. EFFECT: simplified treatment, high antiviral and antiinfectious activity. 5 cl, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
PREPARATION FOR TREATMENT OF VIRAL, CHLAMYDIOSIS AND BACTERIAL INFECTIONS | 1992 |
|
RU2057544C1 |
THERAPEUTICAL AGENT, USES THEREOF AND METHOD FOR DISEASES TREATMENT AND PROPHYLAXIS | 2005 |
|
RU2306144C1 |
MEDICINAL AND PROPHYLACTIC PREPARATION "EUCOPHYT" | 1992 |
|
RU2112532C1 |
METHOD OF TREATMENT OF SCAR-MODIFIED TISSUE | 1998 |
|
RU2150957C1 |
RECOMBINANT INTERFERON-BASE ANTIVIRAL AGENT AS OINTMENT, SUPPOSITORY, CREAM, LINIMENT | 1999 |
|
RU2150291C1 |
EIFITOL FISH OIL PRODUCTION METHOD | 2010 |
|
RU2456336C1 |
STABILISED IMMUNE-CORRECTIVE DRUG VIFERON-FORTE FOR TREATING INFECTIOUS-INFLAMMATORY DISEASES | 2008 |
|
RU2381812C1 |
SET "PREDSTAR", ITS APPLICATION AND METHOD OF PREVENTION OF PREMATURE ORGANISM AGING | 2007 |
|
RU2351350C1 |
RECTAL SUPPOSITORIES AND DEVICE FOR INTRODUCTION THEREOF | 1991 |
|
RU2024253C1 |
ANTIVIRAL AGENT IN LIQUID FORM AND METHOD FOR ITS PREPARATION | 2021 |
|
RU2768656C1 |
Authors
Dates
1997-11-27—Published
1992-02-11—Filed